Andrew Dorsey

Andrew Dorsey is a formulation research associate at Verve Therapeutics. Prior to joining, Andrew completed two co-ops; first with Lyndra Therapeutics, contributing to formulation work for extended drug release in schizophrenia and Alzheimer’s projects and the other with Takeda Pharmaceutical, in the process chemistry and development group, where he led solubility studies and validation of equipment for the evaluation of alternative step solvents, as well as, assisted with green chemistry evaluation of department projects. He earned a B.S and M.S. in chemical engineering from Northeastern University.